Emerging rapidly growing nontuberculous mycobacteria: a retrospective analysis of pulmonary and extrapulmonary isolates and antimicrobial susceptibility

Puneeta Singh; Shalabh Malik; Vandana Lal

doi:10.18203/2320-6012.ijrms20260385

Authors

Puneeta Singh Department of Microbiology, Dr Lal Path Labs, Delhi, India
Shalabh Malik Department of Microbiology, Dr Lal Path Labs, Delhi, India
Vandana Lal Dr Lal Path Labs, Delhi, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260385

Keywords:

Nontuberculous mycobacteria, Rapidly growing nontuberculous mycobacteria, Antibiotic susceptibility testing, Mycobacterium tuberculosis complex, Mycobacterium abscessus, Mycobacterium fortuitum

Abstract

Introduction: Rapidly growing nontuberculous mycobacteria (RGM) account for nearly half of all recognized NTM species and are reported more frequently in Asia than in Western regions. Despite this, data describing RGM infections from North India remain sparse. We evaluated the incidence, species distribution, and antimicrobial susceptibility profiles of pulmonary and extrapulmonary RGM isolates from Delhi, North India.

Methods: A total of 3,624 NTM isolates recovered from pulmonary and extrapulmonary specimens were analyzed. Species identification was performed using MALDI-TOF MS, and antimicrobial susceptibility testing was conducted by broth microdilution in accordance with American Thoracic Society/Infectious Diseases Society of America guidelines. This analysis is limited to culture-positive RGM isolates and does not differentiate colonization from clinically significant disease.

Results: Among 26,475 mycobacterial isolates, 3,624 (12.1%) were identified as NTM, of which 2,115 (58.3%) were RGM. The Mycobacterium abscessus complex predominated (80.9%), followed by the M. fortuitum group (17.6%); other RGM species were infrequently isolated. RGM were recovered from both pulmonary and extrapulmonary specimens. Antimicrobial susceptibility testing demonstrated the highest in vitro activity for Amikacin, Clarithromycin, and Linezolid, with marked interspecies variability and frequent multidrug resistance, particularly among M. abscessus complex isolates.

Conclusions: Despite India being highly endemic for tuberculosis, the epidemiology of NTM particularly RGM remains insufficiently characterized. The findings highlight substantial species diversity and high levels of antimicrobial resistance among RGM isolates in North India, including extensive antimicrobial resistance M. abscessus. These data underscore the importance of accurate species-level identification, routine susceptibility testing, and sustained regional surveillance to optimize management and monitor evolving resistance trends.

Metrics

Metrics Loading ...

References

Ahmed I, Jabeen K, Hasan R. Identification of non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital: a cross-sectional study. BMC Infect Dis. 2013;13:493.

Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med. 2002;23(3):623-32.

Maleki MR. Species and genetic diversity of nontuberculous mycobacteria in suspected tuberculosis cases in East Azerbaijan, Iran: a cross-sectional analysis. Front. Cell. Infect. Microbiol. 2024;14:1477015.

Wani SR, Wattal C, Raveendran R. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region. Indian J Med Microbiol 2020;38:169-75.

Rout SS, Turuk J, Giri SKA, Kumar S, Mohanty T, Panda S, et al. Non-tuberculosis mycobacterial infection among clinically suspected tuberculosis in eastern India (2019-2023). J Infect Public Health. 2025;18(10):102888.

Dumic I, Lutwick L. Successful treatment of rapid growing mycobacterial infections with source control alone: Case series. ID Cases. 2021;26:1332.

Kumar K, Ponnuswamy A, Capstick TG, Chen C, McCabe D. Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management. Clin Med (Lond). 2024;24(1):100017.

Cowman S, Ingen JV, Griffith DE. Non-tuberculous mycobacterial pulmonary disease. European Resp J. 2019;54(1):1900250.

Howard ST, Byrd TF. The rapidly growing mycobacteria: saprophytes and parasites. Microbes Infect. 2000;2(15):1845-53.

Kiselinova M, Naesens L, Huis In 't Veld D, Boelens J, Van Braeckel E, Vande Weygaerde Y, Callens S. Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review. Pathogens. 2023;13(1):12.

Maurya AK, Nag VL, Kant S, Kushwaha RA, Kumar M. Prevalence of nontuberculous mycobacteria among extrapulmonary tuberculosis cases in tertiary care centers in Northern India. Biomed Res Int. 2015;2:465403.

Kim S, Kim AR, Bae M, Lim S, Lee SJ. Clinical characteristics and outcomes of extrapulmonary nontuberculous mycobacterial infections in a tertiary-care hospital: a retrospective study. J Clin Med. 2024;13(15):4373.

Barai L, Saha MR, Rahman T, Sukanya M, Ferdous J. Pattern of rapidly growing mycobacteria (RGM) species isolated from clinical samples: A 10-year retrospective study in a tertiary care hospital of Bangladesh. Indian J Med Microbiol. 2025;53:100756.

Rath S, Firdaus S, Nayak G, Mohanty M. Extrapulmonary Nontuberculous Mycobacteria Infection: The New-Age Neglected Infectious Disease. Cureus. 2025;17(3):81017.

Sali G, Kalavampara SV, Kandasamy SG, Kumar A, Mathew G, Thomas A. Genitourinary non-tuberculous mycobacterial (GU-NTM) infections: A single institution experience in South India. Indian J Tuberc. 2021;68(1):65-72.

Clinical Laboratory Standards Institute. Susceptibility Testing of Mycobateria, Nocardiae, and Other Aerobic Actinomyctes; Approved Standard. 3rd ed. CLSI document M24-A2. Wayne, Clinical and Laboratory Standards Institute. 2018.

Sharma P, Singh D, Sharma K, Verma S, Mahajan S, Kanga A. Are We Neglecting Nontuberculous Mycobacteria Just as Laboratory Contaminants. Time to Reevaluate Things. J Pathog. 2018;4:968.

Harada K, Vu QT, Nishimura Y, Takeda T, Hamano H, Minato Y, et al. Trends in nontuberculous mycobacterial disease mortality based on 2000-2022 data from 83 countries. Int J Infect Dis. 2025;158:107932.

Shrivastava K, Kumar C, Singh A, Narang A, Giri A. An overview of pulmonary infections due to rapidly growing mycobacteria in South Asia and impressions from a subtropical region. Int J Mycobacteriol. 2020;9(1):62-70.

Lin SS, Lee CC, Jang TN. Soft Tissue Infection Caused by Rapid Growing Mycobacterium following Medical Procedures: Two Case Reports and Literature Review. Ann Dermatol. 2014;26(2):236-40.